The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProvexis Share News (PXS)

Share Price Information for Provexis (PXS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.60
Bid: 0.55
Ask: 0.65
Change: 0.00 (0.00%)
Spread: 0.10 (18.182%)
Open: 0.60
High: 0.00
Low: 0.00
Prev. Close: 0.60
PXS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Learning Technologies confident of progress

Wed, 22nd Jun 2022 11:00

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

----------

AIM - WINNERS

----------

Provexis PLC, up 16% at 1.00 pence, 12-month range 0.7p-1.15p. Enters transfer of business agreement and a premix and market-ready solutions supply agreement for heart-health functional food ingredient Fruitflow, both with effect from the start of 2023, after talks with DSM Nutritional Products to replace their alliance agreement which runs to the end of 2022. Also files new patent application relating to the use of Fruitflow to confer health benefits in modulating the gut microbiome of humans.

----------

Learning Technologies Group PLC, up 4.7% at 114.4p, 12-month range 105p-239p. Reports continuation of strong business momentum into the first half of 2022. The London-based digital learning and talent management services provider says the acquisition of GP Strategies has progressed ahead of plan, providing the expanded company with a platform to gain a further stake in the digital learning and talent management market. "While mindful of the current macro environment, strong business momentum has continued into the first half of 2022 and we have a robust balance sheet that will support further strategic acquisitions in due course, underpinning the board's confidence of significant progress," says Chair Andrew Brode.

----------

AIM - LOSERS

----------

Corcel PLC, down 13% at 0.8961p, 12-month range 0.9p-2.2p. The mining and mineral resource development company says all parties have mutually agreed to end the company's marketing rights and the funding efforts associated with the Avonmouth project. The company and Altana, given the "strong bias of Altana and investors more generally" towards non fossil fuel projects, will now focus on energy storage opportunities across the UK. "Whilst it is of course disappointing to end our negotiations on Avonmouth after many months of effort, we recognize the practical dominance of ESG sentiments with infrastructure and energy investors," says Chief Executive Scott Kaintz.

----------

Xeros Technology Group PLC, down 11% at 37.00p, 12-month range 32p-248p. The environmental technology firm says revenue for 2021 rises to GBP474,000 from GBP385,000 in 2020. Pretax loss narrows to GBP6.9 million from GBP7.6 million. Expects to achieve cash breakeven in 2024 and profitability at the earnings before interest, tax, depreciation and amortisation level.

----------

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
3 Dec 2009 08:49

Small caps round-up: Landore Resources, TXO, Aortech...

Shares in Landore Resources jumped after the Canadian miner said it made a 'significant gold discovery' in its Junior Lake property in the province of Ontario. Shares in Texas-focused oil and gas firm TXO slumped after it said oil production in the six months to September 30 fell to 13,221 barrels

Read more
3 Nov 2009 12:16

Small cap round-up: Provexis, Puricore, Sirius, Sopheon, Spiritel

Food technology group Provexis says it has been told that the European Commission review into the health claim wording for its Fruitflow anti-thrombatic technology for use on consumer products is now in "an advanced stage". Puricore's third quarter sales rose 25% to $10.8m, with the nine month tot

Read more
11 Aug 2009 09:30

Provexis surges on Crohn's disease trial

Provexis, the life-science business, has begun a clinical trial for its NSP#3G plantain medical food for Crohn's disease patients. "With the trial now starting and combined with recently obtained healthy human data, the Company will now commence seeking to identify potential global license or co-de

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.